CLINICAL_TRIALS
trial_result
· 2021-08-03
Clinical Trial Update: Antioxidant Therapy to Reduce Inflammation in Sickle Cell Disease [Phase 2]
Summary
Phase 2 trial evaluating antioxidant therapy to reduce inflammation in sickle cell disease has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: UCSF Benioff Children's Hospital Oakland | Conditions: Anemia, Sickle Cell | Phase 2 | Status: COMPLETED | Results posted: 2021-08-03